Snail venom holds promise for cancer therapies

15 January 2015

A new study has found that snail venom could potentially be used to treat and detect cancer.

Professor Frank Mari, from the Department of Chemistry and Biochemistry at Florida Atlantic University's Charles E. Schmidt College of Science, said that venom from marine molluscs like cone snails is used to immobilise prey such as worms. 

The venom selectively target cells in the body, which makes them of powerful potential use for drug development. In addition, it is hoped that knowing more about the venom will enable researchers to understand the human body's processes better.

One class of venom components, of which there are many, is the alpha-conotoxins that target  nicotinic receptors, which are linked to a range of diseases from Alzheimer's disease to lung cancer and schizophrenia.

Published in the Journal of Biological Chemistry, the study focused on the the venom of a particular species of cone snail - Conus regius.

Professor Marí said: "Our aim is to open new avenues for cancer and addiction research inspired on compounds from marine animals."

Posted by ​Edward Bartel 


Health News is provided by Adfero in collaboration with Spire Healthcare. Please note that all copy above is ©Adfero Ltd. and does not reflect views or opinions of Spire Healthcare unless explicitly stated. Additional comments on the page from individual Spire consultants do not necessarily reflect the views or opinions of other consultants or Spire Healthcare.


Find a treatment, test or scan available at:


Find a consultant

Use one or more of the options below to search for a consultant and link through to view their Spire profile.


Let us help you

fill out this form and we will get back to you:

Please select a hospital

We can call you

Please enter your details below and we will call you back.

What is the aim of your enquiry?

Please select a hospital

If we are unable to reach you by phone, please include your email address so that we can get in touch...



© Spire Healthcare Group plc (2016)